50
Views
8
CrossRef citations to date
0
Altmetric
Review

Endophthalmitis: classification and current management

, &
Pages 385-396 | Published online: 09 Jan 2014

References

  • Doft B.Endophthalmitis Management. Focal Points: Modules for Clinicians. American Academy of Ophthalmology, CA, USA (1997).
  • Rosenberg KD, Flynn HW Jr, Alfonso EC, Miller D. Fusarium endophthalmitis following keratitis associated with contact lenses. Ophthalmic Surg. Lasers Imaging37, 310–313 (2006).
  • Jonas JB, Kreissig I, Spandau UH, Harder B. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide. Am. J. Ophthalmol.141, 579–580 (2006).
  • Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch. Ophthalmol.113, 1479–1496 (1995).
  • Clark WL, Kaiser PK, Flynn HW Jr et al. Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis. Ophthalmology106, 1665–1670 (1999).
  • Chaudhry NA, Flynn HW Jr, Smiddy WE et al. Xanthomonas maltophilia endophthalmitis after cataract surgery. Arch. Ophthalmol.188, 572–575 (2000).
  • Scott IU, Lieb DF, Flynn HW Jr et al. Endophthalmitis caused by Mycobacterium chelonae: selection of antibiotics and outcomes of treatment. Arch. Ophthalmol.121, 573–576 (2003).
  • Song A, Scott IU, Flynn HW Jr, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology109, 985–991 (2002).
  • Vahey JB, Flynn HW Jr. Results in the management of Bacillus endophthalmitis. Ophthalmic Surg.22, 681–686 (1991).
  • Schiedler V, Scott IU, Flynn HW Jr et al. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am. J. Ophthalmol.137(4), 725–731 (2004).
  • Scott IU, Matharoo N, Flynn HW Jr, Miller D. Endophthalmitis caused by Klebsiella species. Am. J. Ophthalmol.138, 662–663 (2004).
  • Miller JJ, Scott IU, Flynn HW Jr et al. Endophthalmitis caused by Streptococcus pneumoniae. Am. J. Ophthalmol.138, 231–236 (2004).
  • Scott IU, Flynn HW Jr, Feuer W et al. Endophthalmitis associated with microbial keratitis. Ophthalmology103, 1864–1870 (1996).
  • Alfonso EC, Cantu-Dibildox J, Munir WM et al. Insurgence of Fusarium keratitis associated with contact lens wear. Arch. Ophthalmol.124, 941–947 (2006).
  • Chang DC, Grant GB, O’Donnell K et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA296(8), 953–963 (2006).
  • Iyer SA, Tuli SS, Wagoner RC. Fungal keratitis: emerging trends and treatment outcomes. Eye Contact Lens32, 267–271 (2006).
  • Xie L, Zhong W, Shi W, Sun S. Spectrum of fungal keratitis in north China. Ophthalmology113, 1943–1948 (2006).
  • Dursun D, Fernandez V, Miller D, Alfonso EC. Advanced Fusarium keratitis progressing to endophthalmitis. Cornea22, 300–303 (2003).
  • Moshfeghi DM, Kaiser PK, Bakri SJ et al. Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection. Ophthalmic Surg. Lasers Imaging36, 24–29 (2005).
  • Lundstrom M, Wejde G, Stenevi U, Thorburn W, Montan P. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology114(5), 866–870 (2007).
  • Patwardhan A, Rao GP, Saha K, Craig EA. Incidence and outcomes evaluation of endophthalmitis management after phacoemulsification and 3-piece silicone intraocular lens implantation over 6 years in a single eye unit. J. Cataract Refract. Surg.32, 1018–1021 (2006).
  • Kamalarajah S, Silvestri G, Sharma N et al. Surveillance of endophthalmitis following cataract surgery in the UK. Eye18, 580–587 (2004).
  • Miller JJ, Scott IU, Flynn HW Jr et al. Acute-onset endophthalmitis after cataract surgery (2000–2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am. J. Ophthalmol.139, 983–987 (2005).
  • Eifrig CWG, Flynn HW Jr, Scott IU, Newton J. Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes. Ophthalmic Surg. Lasers33, 373–378 (2002).
  • West ES, Behrens A, McDonnell PJ et al. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology112, 1388–1394 (2005).
  • Wallin T, Parker J, Jin Y, Kefalopoulos G, Olson RJ. Cohort study of 27 cases of endophthalmitis at a single institution. J. Cataract Refract. Surg.31, 735–741 (2005).
  • Bucher RS, Hall E, Reed DM et al. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment. Arch. Ophthalmol.123, 649–653 (2005).
  • Taylor SRJ, Aylward GW. Endophthalmitis following 25-gauge vitrectomy. Eye19, 1228–1229 (2004).
  • Taban M, Ufret-Vincenty RL, Sears JE. Endophthalmitis after 25-gague transconjunctival sutureless vitrectomy. Retina26(7), 830–831 (2006).
  • Busbee BG. Endophthalmitis: a reappraisal of incidence and treatment. Curr. Opin. Ophthalmol.17, 286–291 (2006).
  • Essex RW, Yi Q, Charles PG, Allen PJ. Post-traumatic endophthalmitis. Ophthalmology111, 2015–2022 (2004).
  • Gragoudas ES, Adamis AP, Cunningham ET Jr et al. Pegaptanib for neovascular age-related macular degeneration. N. Engl. J. Med.351, 2805–2816 (2004).
  • Heier JS, Antoszyk AN, Pavan PR et al. Ranibizumab for treatment of neovascular age-related macular degeneration: a Phase I/II multicenter, controlled, multidose study. Ophthalmology133, 633–642 (2006).
  • Brown DM, Kaiser PK, Michels M et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med.355(14), 1432–1444 (2006).
  • Rosenfeld PR, Brown DM, Heier JS et al. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med.355(14), 1419–1431 (2006).
  • Westfall AC, Osborn A, Kuhl D et al. Acute endophthalmitis incidence: intravitreal triamcinolone. Arch. Ophthalmol.123, 1075–1077 (2005).
  • Fung AE, Rosenfeld PJ, Reichel E. The international intravitreal bevacizumab safety survey: using the internet to assess drug safety worldwide. Br. J. Ophthalmol.90, 1344–1349 (2006).
  • Moshfeghi DM, Kaiser PK, Scott IU et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am. J. Ophthalmol.136, 791–796 (2003).
  • Aiello LP, Brucker AJ, Chang S et al. Evolving guidelines for intravitreous injections. Retina24(5 Suppl.), S3–S19 (2004).
  • Donahue SP, Kowalski RP, Jewart BH, Friberg TR. Vitreous cultures in suspected endophthalmitis: biopsy or vitrectomy? Ophthalmology100, 452–455 (1993).
  • Josephberg RG. Endophthalmitis: the latest in current management. Retina26(6 Suppl.), S47–S50 (2006).
  • Hilton GF, Josephberg RG, Halperin LS et al. Office-based sutureless transconjunctival pars plana vitrectomy. Retina22, 725–732 (2002).
  • Irvine WD, Flynn HW Jr, Murray TG, Rubsamen PE. Retained lens fragments after phacoemulsification manifesting as marked intraocular inflammation with hypopyon. Am. J. Ophthalmol.114, 610–614 (1992).
  • Mamalis N, Edelhauser HF, Dawson DG, Chew J, LeBoyer RM, Werner L. Toxic anterior segment syndrome. J. Cataract Refract. Surg.32(2), 324–333 (2006).
  • Jehan FS, Mamalis N, Spencer TS et al. Postoperative sterile endophthalmitis (TASS) associated with the Memory Lens. J. Cataract Refract. Surg.26, 1773–1777 (2000).
  • Werner L, Sher JH, Taylor JR et al. Toxic anterior segment syndrome and possible association with ointment in the anterior chamber following cataract surgery. J. Cataract Refract. Surg.32, 227–235 (2006).
  • Smith CA, Khoury JM, Shields SM et al. Unexpected corneal endothelial decompensation after intraocular surgery with instruments sterilized by plasma gas. Ophthalmology107, 1561–1566 (2000).
  • Duffy RE, Brown SE, Caldwell KL et al. An epidemic of corneal destruction caused by plasma gas sterilization: the Toxic Endothelial Cell Destruction Syndrome Investigative Team. Arch. Ophthalmol.188, 1167–1176 (2000).
  • Hellinger WC, Hasan SA, Bacalis LP et al. Outbreak of toxic anterior segment syndrome following cataract surgery associated with impurities in autoclave steam moisture. Infect. Control Hosp. Epidemiol.27, 294–298 (2006).
  • Liu H, Routley I, Teichmann KD. Toxic endothelial cell destruction from intraocular benzalkonium chloride. J. Cataract Refract. Surg.27, 1746–1750 (2001).
  • Eleftheriadis H, Cheong M, Sandeman S et al. Corneal toxicity secondary to inadvertent use of benzalkonium chloride preserved viscoelastic material in cataract surgery. Br. J. Ophthalmol.86, 299–305 (2002).
  • Unal M, Yucel I, Akar Y, Oner A, Altin M. Outbreak of toxic anterior segment syndrome associated with glutaraldehyde after cataract surgery. J. Cataract Refract. Surg.32, 1696–1701 (2006).
  • Moshfeghi AA, Scott IU, Flynn HW Jr, Puliafito CA. Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Am. J. Ophthalmol.138, 489–492 (2004).
  • Nguyen JK, Fung AE, Flynn HW Jr, Scott IU. Hypopyon and pseudoendophthalmitis associated with chronic vitreous hemorrhage. Ophthalmic Surg. Lasers Imaging37, 317–319 (2006).
  • Schwartz SG, Mieler WF, Holz ER et al. Intravitreal hemoglobin spherulosis: a rare complication of subretinal hemorrhage. Arch. Ophthalmol.120, 85–87 (2002).
  • Joondeph BC, Flynn HW Jr, Miller D, Joondeph HC. A new culture method for infectious endophthalmitis. Arch. Ophthalmol.107, 1334–1337 (1989).
  • Anand AR, Madhavan HN, Neela V, Lily T. Use of polymerase chain reaction in the diagnosis of fungal endophthalmitis. Ophthalmology108, 326–330 (2001).
  • Durand M. Microbiologic factors and visual outcome in the Endophthalmitis Vitrectomy Study. Am. J. Ophthalmol.124, 127–130 (1997).
  • Doft DH, Wisniewski SR, Kellsy SF et al. Diabetes and postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study. Arch. Ophthalmol.119, 650–656 (2001).
  • Han DP, Wisniewski SR, Wilson LA et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am. J. Ophthalmol.122, 1–17 (1996).
  • Johnson MW, Doft BH, Kelsey SF et al. The Endophthalmitis Vitrectomy Study: relationship between clinical presentation and microbiologic spectrum. Ophthalmology104, 261–272 (1997).
  • Hariprasad SM, Mieler WF, Holz ER. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch. Ophthalmol.121, 345–350 (2004).
  • Park-Wyllie LY, Juurlink DN, Kopp A et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. N. Engl. J. Med.354, 1352–1361 (2006).
  • Iyer MN, Han DP, Yun HJ et al. Subconjunctival antibiotics for acute postcataract extraction endophthalmitis: is it necessary? Am. J. Ophthalmol.137(6), 1120–1121 (2004).
  • Smiddy WE, Smiddy RJ, Ba’Arath B et al. Subconjunctival antibiotics in the treatment of endophthalmitis managed without vitrectomy. Retina25, 751–758 (2005).
  • Bannerman TL, Rhoden DL, McAllister M et al. The source of coagulase-negative staphylococci in the Endophthlamitis Vitrectomy Study: a comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch. Ophthalmol.115, 357–361 (1997).
  • Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology109, 13–26 (2002).
  • Montan PG, Wejde G, Koranyi G, Rylander M. Prophylactic intracameral cefuroxime: efficacy in preventing endophthalmitis after cataract surgery. J. Cataract Refract. Surg.28, 977–981 (2002).
  • Barry P, Seal DV, Gettinby G et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study. J. Cataract Refract. Surg.32, 407–410 (2006).
  • Busbee BG, Recchia FM, Kaiser R et al. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology111, 1495–1503 (2004).
  • Busbee BG. Update on treatment strategies for bleb-associated endophthalmitis. Curr. Opin. Ophthalmol.16, 170–174 (2005).
  • Pflugfelder SC, Hernandez E, Fliesler SJ et al. Intravitreal vancomycin. Retinal toxicity, clearance, and interaction with gentamicin. Arch. Ophthalmol.105, 831–837 (1987).
  • Pavan PR, Oteiza EE, Hughes BA, Avni A. Exogenous endophthalmitis initially treated without systemic antibiotics. Ophthalmology101, 1289–1296 (1994).
  • Kazi AA, Jermak CM, Peyman GA, Aydin E, Riazi-Esfahani M. Intravitreal toxicity of levofloxacin and gatifloxacin. Ophthalmic Surg. Lasers Imaging37, 224–229 (2006).
  • Gao H, Pennesi ME, Qiao X et al. Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models. Invest. Ophthalmol. Vis. Sci.47, 1606–1611 (2006).
  • Aydin E, Kazi AA, Peyman GA, Esfahani MR. Intravitreal toxicity of moxifloxacin. Retina26, 187–190 (2006).
  • Esfahani MR, Kazi AA, Peyman GA, Dellacroce JT, Aydin E. Intravitreal toxicity of garenoxacin. Retina26, 182–186 (2006).
  • Lakhanpal RR, Humayun MS, de Juan E Jr et al. Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease. Ophthalmology112, 817–824 (2005).
  • Yanyali A, Celik E, Horozoglu F, Oner S, Nohutcu AF. 25-gauge transconjunctival sutureless pars plana vitrectomy. Eur. J. Ophthalmol.16(1), 141–147 (2006).
  • Van Limbergen J, Kalima P, Taheri S, Bettie TF. Streptococcus A in paediatric accident and emergency: are rapid streptococcal tests and clinical examination of any help? Emerg. Med. J.23, 32–34 (2006).
  • Sambursky R, Tauber S, Schirra F, Kozich K, Davidson R, Cohen EJ. The RPS Adeno Detector for diagnosing adenoviral conjunctivits. Ophthalmology113, 1758–1764 (2006).
  • Holz ER. Reducing endophthalmitis risk factors: where we stand. Am. J. Ophthalmol.139, 1097–1098 (2005).
  • Taban M, Sarayba MA, Ignacio TS, Behrens A, McDonnell PJ. Ingress of India ink into the anterior chamber through sutureless clear corneal cataract wounds. Arch. Ophthalmol.123(5), 643–648 (2005).
  • Stewart JM. Wound integrity and the conjunctiva in prevention of endophthalmitis following sutureless 25-gauge vitrectomy. Eye20(12), 1490 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.